This was my 2nd biggest winner last year (after BQI, then CWPC.ob)
Low A/S and float (though recently incresed) Continued insider buying Fantstic management, including a new medical technology-to-market-specialist and a US patent expert.
2 stand alone world class technologies, fully patented:
Landfill Gas CO2 convertor- after a 10 year Dupont contract boosted the PPS last year, disagreements with the landfill operator have delayed the initial installation from becoming commercial. CEO insists it is merely a delay. (With the Dems coming to power, carbon trading will be here to stay)
Live Tissue Connect (LTC) Surgical procedure which connects tissue and organs without staples, sutures or excessive heat. First device to be submitted to the FDA for approval in Q1.
Last year, this company went from .04 to .78 and back to its current PPS of .43 on PRs alone. When the EU and the USA recognise the and accept the LTC procedure, the sky's the limit. The Landfill Gas technology is icing on the cake.
This one belongs to the VMC Zip Code changer board as I doubt we'll see much in the way of revenue or earnings this year, but the potential is massive and the CEo has postured the company for more good news in O7.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.